$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2017 Q2 Form 10-Q Financial Statement

#000114420417043228 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $730.0K $10.00K $0.00
YoY Change 0.0% -100.0%
% of Gross Profit
Research & Development $160.0K
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $890.0K $10.00K $14.11K
YoY Change 6208.48% 0.0% -24.42%
Operating Profit -$14.11K
YoY Change -24.42%
Interest Expense -$410.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.290M -$10.00K -$14.11K
YoY Change 9043.75% 0.0% -24.25%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.62K -$10.00K -$24.70K
YoY Change -4.36% -50.0% 11.53%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$219.8K -$1.972K $0.00
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $520.0K $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $50.00K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $580.0K $0.00
YoY Change 31456.04% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 -$575.7K $4.277K
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $0.00 $580.0K $0.00
Total Long-Term Assets $0.00 -$575.7K $4.277K
Total Assets $0.00 $4.277K $4.277K
YoY Change -100.0% 132.7% 1052.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.00K $22.36K $21.14K
YoY Change 89.21% 105.97% 141.52%
Accrued Expenses $1.498K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $280.0K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $128.5K $117.9K $103.8K
YoY Change 23.78% 41.52% 80.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $350.0K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $350.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $128.5K $117.9K $103.8K
Total Long-Term Liabilities $0.00 $350.0K $0.00
Total Liabilities $130.0K $117.9K $103.8K
YoY Change 25.23% 41.52% 80.58%
SHAREHOLDERS EQUITY
Retained Earnings -$227.8K -$213.7K
YoY Change 26.53% 41.61%
Common Stock $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$130.0K -$113.7K -$99.53K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $4.277K $4.277K
YoY Change -100.0% 132.7% 1052.83%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$23.62K -$10.00K -$24.70K
YoY Change -4.36% -50.0% 11.53%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$560.0K -$20.00K -$10.00K
YoY Change 5500.0% -300.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 490.0K 20.00K 10.00K
YoY Change 4800.0% -300.0%
NET CHANGE
Cash From Operating Activities -560.0K -20.00K -10.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 490.0K 20.00K 10.00K
Net Change In Cash -70.00K 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$560.0K -$20.00K -$10.00K
Capital Expenditures $0.00
Free Cash Flow -$560.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2016Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
4277 USD
CY2017Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
21807 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-23621 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-24699 USD
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2017Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-23621 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-14108 USD
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-10591 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.00
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.00
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-14845 USD
us-gaap Net Income Loss
NetIncomeLoss
-33657 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-32375 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-18493 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
17530 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-15164 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.00
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11572 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8210 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11572 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8210 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
0 USD
CY2015Q4 us-gaap Cash
Cash
0 USD
CY2016Q2 us-gaap Cash
Cash
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8210 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11572 USD
nmtc Increase Decrease In Liabilities From Discontinued Operations
IncreaseDecreaseInLiabilitiesFromDiscontinuedOperations
0 USD
nmtc Increase Decrease In Liabilities From Discontinued Operations
IncreaseDecreaseInLiabilitiesFromDiscontinuedOperations
1986 USD
nmtc Increase Decrease In Assets From Discontinued Operations
IncreaseDecreaseInAssetsFromDiscontinuedOperations
0 USD
nmtc Increase Decrease In Assets From Discontinued Operations
IncreaseDecreaseInAssetsFromDiscontinuedOperations
2439 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
17530 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-15617 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10283 USD
CY2014Q1 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
1 pure
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1498 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
128495 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
117927 USD
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
85330 USD
CY2016Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
73758 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD

Files In Submission

Name View Source Status
0001144204-17-043228-index-headers.html Edgar Link pending
0001144204-17-043228-index.html Edgar Link pending
0001144204-17-043228.txt Edgar Link pending
0001144204-17-043228-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nmtc-20170630.xml Edgar Link completed
nmtc-20170630.xsd Edgar Link pending
nmtc-20170630_cal.xml Edgar Link unprocessable
nmtc-20170630_def.xml Edgar Link unprocessable
nmtc-20170630_lab.xml Edgar Link unprocessable
nmtc-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472986_10q.htm Edgar Link pending
v472986_ex31.htm Edgar Link pending
v472986_ex32.htm Edgar Link pending